| INTRODUCTION
Pompe disease is a metabolic myopathy or lysosomal storage disorder caused by an inheritable deficiency of the lysosomal enzyme acid aglucosidase. Glycogen accumulates progressively in the lysosomes and causes damage to myocytes. Pompe disease presents as a clinical spectrum with a predicted frequency of 1:40 000. The classic infantile form of Pompe disease (1:138 000), represents the most severe end of the spectrum with generalized hypotonia, cardiomyopathy, and respiratory insufficiency as characteristic features. Without enzyme replacement therapy (ERT), these children rarely survive beyond 1 year of age due to cardiorespiratory failure. Patients with nonclassic presentations (1:57 000) may present at any age from early infancy to late adulthood and the course may vary widely. [1] [2] [3] Symptoms relate to skeletal and respiratory muscle weakness and most of the patients become wheelchair bound or dependent on a respirator at some time in life. Since the diaphragm is also involved pulmonary function in supine position is mostly lower than in upright position. In these patients, the heart is rarely involved. 4 The worldwide introduction of ERT with recombinant human acid a-glucosidase in 2006 has altered life expectancy substantially, providing a therapeutic option for this previously untreatable disease. 5, 6 One of the consequences is that these patients are increasingly eligible for surgical procedures, not only procedures related to the disease (insertion of a Port-a-Cath [PAC] for ERT or muscle biopsy) but also common elective surgical and diagnostic procedures. However, its implications for perioperative and anesthesia practice are largely unknown. To date, the anesthetic literature on Pompe disease is limited and knowledge is mainly based on small case series and case reports. [7] [8] [9] [10] In children with the classic infantile form of Pompe disease, fatal perioperative cardiac complications, related to cardiomyopathy, have been described. [7] [8] [9] The heart is rarely affected in children with nonclassic presentations. 11 In addition, serious pulmonary complications due to respiratory muscle weakness, such as repeated (silent) aspiration and prolonged ventilation, are mentioned for both forms of Pompe disease. [12] [13] [14] Bulbar weakness leading to dysphagia as described in both children and adults may also contribute. According to a long-term study in children with classic infantile form of disease receiving ERT, these children suffer from facial muscle weakness, reduced pharyngeal and laryngeal sensibility, and dysphagia, making them more vulnerable for postoperative aspiration. 15, 16 Enzyme replacement therapy was introduced in the Erasmus MC-Sophia Children's Hospital, University Medical Centre, Rotterdam, The Netherlands, already in 1999 as part of the first clinical trial performed, applying recombinant human a-glucosidase produced in milk of transgenic rabbits. 5 In this article, we provide an overview of our anesthetic experience in children with Pompe disease since the introduction of ERT in our hospital. We investigated the incidence of perioperative complications and risk factors making a separation between patients with classic and nonclassic presentations, and attempted to make a recommendation regarding the anesthetic and perioperative management of children with Pompe disease. 
| MATERIALS AND METHODS

| Statistics
Categorical data are described as counts and percentages. Continuous variables are described as medians and interquartile ranges. The relation of influencing factors and occurrence of perioperative complications were analyzed using the Mann-Whitney U and chi-square test. Data were collected and analyzed using IBM SPSS Statistics 22
(IBM Inc., Chicago, IL, USA).
3 | RESULTS
| General parameters
Sixty-five patients with Pompe disease were diagnosed and/or treated in the Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands, between February 1999 until January 2015. During this period, 31 patients had no indication to undergo a procedure requiring anesthesia and were therefore excluded. Our final study sample consisted of 34 children who underwent 1 or more surgical or diagnostic procedures, mostly low risk (Table 1) . Twenty-one (61.7%) of these children had the infantile form and 13 (38.3%)
were children with nonclassic presentations. These 34 children underwent in total 77 procedures: 48 (62.3%) in children with infantile form and 29 (37.7%) in the others. All except 1 child, started to receive ERT at some point during the study period. Six patients with the classic infantile form of disease and 10 children with nonclassic presentations underwent the first procedure before starting ERT (Table 2 ).
| Perioperative parameters
Of the 77 procedures, 71 were performed under general anesthesia.
Six were performed with a local anesthesia technique: 5 diagnostic muscle biopsies with awake caudal anesthesia (2 of these procedures were combined with a local anesthesia for a PAC insertion) and 1 single PAC insertion under local anesthesia. One patient with nonclassic presentation of disease had a tendon release of the foot under general anesthesia, unfortunately exact intraoperative information was missing.
In both forms of Pompe disease, intravenous (IV) induction of anesthesia with propofol was most common. Three children with classic infantile type of disease (6.3%) and 1 child with nonclassic presentation (3.4%) had an induction with ketamine. For maintenance of anesthesia, IV anesthesia with propofol (dose range 3-15 mg/kg/h) was used more commonly in both forms of Pompe disease (Table 3) .
Over the years we found a change in the anesthesia technique MRI, magnetic resonance imaging; PAC, Port-a-Cath; PEG, percutaneous endoscopic gastrostomy. Table 4 shows the adverse events that occurred perioperatively.
| Adverse events
One or more adverse events occurred in 13 procedures (16.8%): Combination inhalation/IV, n (%) 5 (7) 4 (9) 1 (3) a Missing data for 1 procedure for a patient with nonclassic presentation of disease, who had general anesthesia. The exact choice of anesthetic agents is missing. We compared for both forms of disease the groups with and without perioperative complications for several relevant parameters, (such as age at start of ERT, cardiac and respiratory status, anesthesia technique used) to determine a possible risk factor for perioperative adverse events (Table 4) . However, we could not demonstrate any relationship between these parameters and the occurrence of adverse events in both groups. The study sample was too small for a reliable and definite statistical analysis.
| DISCUSSION
The purpose of this study was to determine the incidence and sever- Given the respiratory muscle weakness in children with Pompe and the severe cardiomyopathy in children with classic infantile type of disease, we expected to find more complications. Literature about Pompe disease and anesthesia is limited, but the case series and reports available show serious anesthetic complications. [7] [8] [9] The fact that during the first years of our study (1999) (2000) (2001) (2002) (2003) (2004) ), the anesthetic record was still written manually, instead of Moderate or severe systolic dysfunction (n) 14, 17 We advocate to focus on these aspects prior to the initiation of an anesthetic procedure.
Also in healthy children, respiratory complications are the most common adverse events during general anesthesia. A study in 9297 children undergoing surgery, showed an incidence of 15% respiratory adverse events perioperatively. 20 In 10% of the children, a period of desaturation <95% was described. The incidence of perioperative desaturation for children with Pompe disease in this study is higher than in the general pediatric population, even when a different definition of desaturation is taken into account (<90% vs 95%). In our study, the period of desaturation had no further implications for treatment.
Excessive accumulation of glycogen within the lysosomes of many tissues, including cardiac muscle cells, leads to a progressive cardiomyopathy in children with the classic infantile form of Pompe disease. 3, 4 At the time of diagnosis, a severe cardiomyopathy and cardiac failure is present in most children, generating a high risk on the occurrence of anesthetic complications. In children with nonclassic presentations, the heart is sporadically affected. 13 A noncompliant left ventricle predisposes a patient to diastolic heart failure, an elevated left ventricular end diastolic pressure and common development of systolic heart failure. [7] [8] [9] Glycogen accumulation can also be situated in the cardiac conduction system, leading to abnormal conduction velocities. 21 The combination of factors makes children with the classic infantile form of disease especially vulnerable to develop a ventricular and supraventricular tachycardia. This fragile balance represents a challenge for a safe anesthetic procedure. In the current study, we found cardiac arrhythmias in 2 children with classic infantile form of disease and in 1 child with nonclassic form of disease. In 2 cases, the arrhythmia was probably related to the insertion of a PAC. Ing et al described a case series of 5 children with the classic infantile form, undergoing a total of 13 anesthetics. During one of these procedures, a cardiac arrest occurred, followed by a successful defibrillation procedure. In 2 cases, ST-segment depression occurred, normalizing after administration of phenylephrine. 9 Wang et al screened 139 patients with Pompe disease for adverse events during anesthesia. They describe 9 patients experiencing serious cardiac arrhythmia or arrest soon after induction of anesthesia. This article suggests an association between LV mass indices and mortality risk, as a LV mass index >350 g/m 2 was associated with death in children with classic infantile form of disease. 7 In our study none of the children had LV mass indices in this range when undergoing anesthesia.
In the study of Ing et al, 9 all complications occurred in the group of children who were not on ERT. The exact duration of ERT at the time of the anesthesia was not mentioned in the article of Wang et al. 7 In our study, the median time of ERT before the first anesthesia in children with classic infantile type of disease was 3 months, as most of the children were given ERT by peripheral infusion before undergoing a PAC insertion under anesthesia. One of the most important reasons to start ERT first on a peripheral infusion and to insert a PAC later was to increase the stability of the child first, prior to any (elective) intervention requiring general anesthesia. During the first 3 months of treatment, we monitor cardiac hypertrophy and function on a monthly basis and every 3 months thereafter. [14] [15] [16] [17] [18] [19] [20] [21] [22] Once the risk of cardiac and respiratory failure seems reduced, general anesthesia is considered.
Other factors that may have contributed to a better outcome is that we focus on potential signs and symptoms of bulbar muscle weakness, respiratory difficulties, and infections which may increase the risk of aspiration. 15 Preoperative polysomnography is performed when there are doubts. In older children, spirometry in sitting and supine position is performed. All of these measures probably provide an important explanation of our relatively low percentage of complications. Also the fact that children receive a higher dose of ERT in our hospital may have contributed to a better preoperative stability. 23 We did not find a relation with anesthetic technique used and complication rate. From the sparse available literature on anesthesia in children with classic infantile form of disease, the common sense is that additional care in maximizing coronary perfusion pressure and minimizing arrhythmia risk must be given. For these reasons, it was recommended to avoid propofol or high concentrations of sevoflurane. In other studies, agents such as ketamine and etomidate were advised as the cornerstone for induction in order to better support coronary perfusion pressure and to avoid decreasing diastolic blood pressure with vasodilatory agents. [7] [8] [9] However, since the introduction of ERT and with children in a physically better condition, propofol and sevoflurane
were used in our hospital to anesthetize children with Pompe disease. The results of our study suggest that these anesthetic agents can be used safely in children with Pompe on ERT provided that a careful preoperative workup has taken place. Ketamine and etomidate, or the use of a local anesthetic technique still should be considered in children with severe cardiomyopathy.
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| CONCLUSIONS
The purpose of this study was to determine the incidence and severity of perioperative complications for children with Pompe disease, and to identify predictive factors for poor anesthetic out- 
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